Overcoming Engineering Challenges to Enable Commercial-Scale mRNA Vaccine Manufacturing: This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities
| Publicado en: | BioPharm International Vol. 35; no. 8; pp. 36 - 41 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |